Results 21 to 30 of about 21,252 (207)

Anaphylaxis caused by taking pantoprazole: case series

European Journal of Case Reports in Internal Medicine, 2023
Introduction: Pantoprazole is one of the most widely used proton pump inhibitors, but anaphylaxis occurs rarely during its use. The purpose of reporting these two cases is to show that pantoprazole is not a drug without problems; it can also cause ...
Skender Telaku, Arber Veliu, Qendrim Zenelaj, Mimoza Telaku, Hajrullah Fejza, Fitim Alidema   +5 more
doaj   +1 more source

Use of gastroprotective agents in recommended doses in hospitalized patients receiving NSAIDs: a drug utilization study [PDF]

, 2006
OBJECTIVE: In recent years, studies investigated to what extend recommendations for co-prescribing gastroprotective agents in prevention of NSAID-induced gastrointestinal complications are followed in clinical practice.
Bilušić, Marinko, Erdeljić, Viktorija, Francetić, Igor, Huić, Mirjana, Macolić Šarinić, Viola, Makar-Aušperger, Ksenija, Merčep, Iveta   +6 more
core   +1 more source

Validação de metodologia analítica por cromatografia líquida para doseamento e estudo da estabilidade de pantoprazol sódico Validation of analytical methodology by hplc for quantification and stability evaluation of sodium pantoprazole

Química Nova, 2007
Pantoprazole is a proton pump inhibitor used in the treatment of digestive ulcers, gastro-esophageal reflux disease and in the eradication of Helicobacter pylori.
Renata Platcheck Raffin, Letícia Marques Colomé, Sílvia Stanisçuaski Guterres, Adriana Raffin Pohlmann   +3 more
doaj   +1 more source

Continuous Infusion of Pantoprazole with Octreotide Does Not Improve Management of Variceal Hemorrhage [PDF]

, 2009
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90065/1/phco.29.3.248 ...
Alaniz, Cesar, Mohammad, Rima A., Welage, Lynda S.   +2 more
core   +1 more source

A retrospective analysis of clinical outcomes between hospitalized patients with COVID‐19 who received famotidine or pantoprazole

JGH Open, 2023
Background and Aim There is limited research on the use of histamine‐H2 receptor antagonists and proton pump inhibitors for treating COVID‐19. We compare clinical outcomes between patients hospitalized with COVID‐19 receiving famotidine or pantoprazole ...
Justin J. Wagner, Nikolas St. Cyr, Aaron Douen, Joshua Fogel, John Trillo   +4 more
doaj   +1 more source

Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves

Frontiers in Veterinary Science, 2023
IntroductionDevelopment of abomasal ulceration is a large concern, especially within calves; however, there is a paucity of research into the use of gastro protectants in ruminant species.
Jeff D. Olivarez, Pierre-Yves Mulon, Lisa S. Ebner, Haley Cremerius, Channing Cantrell, Rebecca Rahn, Windy Soto-Gonzalez, Joan Bergman, Sherry Cox, Jonathan P. Mochel, Amanda J. Kreuder, Joe S. Smith, Joe S. Smith   +12 more
doaj   +1 more source

Pharmacologic Properties of Proton Pump Inhibitors [PDF]

, 2003
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90231/1/phco.23.13.74S.31929 ...
Welage, Lynda S.
core   +1 more source

Stereoselective Biotransformation: Transfer of Learning to Advance Drug Metabolism and Biocatalysis

Angewandte Chemie, EarlyView.
Understanding stereoselective biotransformations has implications for predicting drug disposition and response and may also inspire novel biocatalytic and biomimetic strategies to address challenges in metabolite and API synthesis. ABSTRACT Chirality is an important determinant of drug action, as enantiomers can exhibit markedly different ...
Grace A. Okunlola, Godwin A. Aleku
wiley   +2 more sources

Investigating the Use of Pantoprazole in Yazd Shahid Rahnemoon Hospital, 2019

Journal of Mazandaran University of Medical Sciences, 2022
Background and purpose: Proton pump inhibitors (PPIs) are one of the main therapeutic agents for acid-related diseases. Pantoprazole, with minimal drug interaction, is one of the well-known PPIs.
Adeleh Sahebnasagh, Ali Basiratian, Amirhossein Zahmatkesh, Majid Hajimaghsoudi, Fatemeh Saghafi   +4 more
doaj  

Physical and Chemical Properties and Methods of Control of Pantoprazol Sodium Sesquihydrate (Review)

Разработка и регистрация лекарственных средств, 2020
Introduction. Pantoprazole sodium sesquihydrate is a proton pump inhibitor. This substance is used in the treatment of peptic ulcer of the duodenum or stomach in the acute phase, including those associated with the use of non-steroidal anti-inflammatory ...
V. A. Shelekhova, K. R. Savelyeva, S. V. Polyakov, V. N. Shestakov   +3 more
doaj   +1 more source